Samuelson Doug
SEC CIK 1943326 · EDGAR
BoughtSold
Most active insiders at KAPA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samuelson Doug | CFO | — | — |
| 2 | Bhowmick Neil | CSO | — | — |
| 3 | Murali Ramachandran | VP of Research, Development | — | — |
| 4 | Yu John S | CEO, COB, Dir, 10% | — | — |
| 5 | Singhvi Rahul | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | 2025-10-08 | KAPA | Kairos Pharma, LTD. | Samuelson Doug | CFO | A - Grant | $0.00 | +152.7K | 293.0K | +109% | $0 | |
| 2024-11-25 | 2024-11-22 | KAPA | Kairos Pharma, LTD. | Samuelson Doug | CFO | P - Purchase | $1.50 | +2,500 | 60.8K | +4% | +$3,750 | |
| 2023-08-22 | 2023-08-18 | GNLX | GENELUX Corp | Samuelson Doug | CFO | S - Sale | $23.73 | -1,297 | 2,303 | -36% | -$30.8K | |
| 2023-05-02 | 2023-02-17 | GNLX | GENELUX Corp | Samuelson Doug | CFO | A - Grant | $0.00 | +3,600 | 3,600 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations